Document is current

Indications to respiratory syncytial virus immunoprophylaxis in the 29–32 wGA group: is there still room for debating?

Crossref DOI link: https://doi.org/10.1186/S13052-017-0341-4

Published: 2017-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY